Covered recipient · General Payments record
ZACHARY PETER MACINSKI
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2022
$617.53
- Reported across 34 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $315.59 | 16 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| UCB, Inc. | $66.27 | 4 |
| JAZZ PHARMACEUTICALS INC. | $64.22 | 1 |
| Amneal Pharmaceuticals LLC | $33.53 | 2 |
| ACADIA Pharmaceuticals Inc | $27.23 | 2 |
| ABBVIE INC. | $23.64 | 1 |
| Biogen, Inc. | $21.81 | 1 |
| EMD Serono, Inc. | $21.00 | 1 |
| Neurocrine BioSciences, Inc. | $16.34 | 1 |
| Amgen Inc. | $15.52 | 1 |
| Neurelis, Inc. | $13.50 | 1 |
| Sunovion Pharmaceuticals Inc. | $12.53 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.64 | 04/26/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891068601 | CMS |
| ACADIA Pharmaceuticals Inc | $15.09 | 02/25/2022 | Food and Beverage | Undisputed | 01/23/2026 | 952387575 | CMS |
| ACADIA Pharmaceuticals Inc | $12.14 | 06/30/2022 | Food and Beverage | Undisputed | 01/23/2026 | 952387577 | CMS |
| Amgen Inc. | $15.52 | 05/26/2022 | Food and Beverage | Undisputed | 01/23/2026 | 939384827 | CMS |
| Amneal Pharmaceuticals LLC | $19.94 | 03/15/2022 | Food and Beverage | Undisputed | 01/23/2026 | 956586059 | CMS |
| Amneal Pharmaceuticals LLC | $13.59 | 06/21/2022 | Food and Beverage | Undisputed | 01/23/2026 | 956586063 | CMS |
| Biogen, Inc. | $21.81 | 06/23/2022 | Food and Beverage | Undisputed | 01/23/2026 | 923417553 | CMS |
| EMD Serono, Inc. | $21.00 | 04/05/2022 | Food and Beverage | Undisputed | 01/23/2026 | 941503727 | CMS |
| JAZZ PHARMACEUTICALS INC. | $64.22 | 05/19/2022 | Food and Beverage | Undisputed | 01/23/2026 | 951381575 | CMS |
| Neurelis, Inc. | $13.50 | 04/19/2022 | Food and Beverage | Undisputed | 01/23/2026 | 950154109 | CMS |
| Neurocrine Biosciences, Inc. | $16.34 | 05/31/2022 | Food and Beverage | Undisputed | 01/23/2026 | 963322723 | CMS |
| Sunovion Pharmaceuticals Inc. | $12.53 | 01/27/2022 | Food and Beverage | Undisputed | 01/23/2026 | 921082809 | CMS |
| UCB, Inc. | $15.00 | 01/06/2022 | Food and Beverage | Undisputed | 01/23/2026 | 908005887 | CMS |
| UCB, Inc. | $20.11 | 03/22/2022 | Food and Beverage | Undisputed | 01/23/2026 | 908005893 | CMS |
| UCB, Inc. | $15.59 | 05/05/2022 | Food and Beverage | Undisputed | 01/23/2026 | 908005891 | CMS |
| UCB, Inc. | $15.57 | 05/25/2022 | Food and Beverage | Undisputed | 01/23/2026 | 908005889 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.